Welcome to the July 2022 edition of the HTA Monthly Wrap. We had a fantastic gathering of sector stakeholders at Healthtech Week 2022 at the end of June, followed by the Demo Night for the HealthTech Supernode Challenge in mid-July - with both events demonstrating the strength of the NZ healthtech ecosystem.
Healthtech Week 2022 included awards for several NZ companies: Helico Bio and Virtual Medical Coaching were joint winners of the Callaghan Innovation HealthTech Award for Best Scale-up Company; Obex Medicaland HeartLab received the James & Wells MTANZ Innovation and Manufacturing & Export awards respectively; and Kitea Health nabbed the HealthTech Award for Best Translational Research Project.
Turning to the South Island, Vibration Action won the Te Papa Hauora Innovation Prize at the HealthTech Supernode Challenge Demo Night in Christchurch - a cash prize to support their commercialisation journey - and a special mention too for Callaghan Innovation staffer Strath McKenzie, who was one of the nine finalists as founder of dementia app re:Yesterday.
In this edition’s HTA news, we’re pleased to share a blog from our market validation workshop provider, Apagie, discussing collaboration insights from the leading US orthopaedic hospital, and we also share the recording of our June 2022 HTA European Market Access for Medical Devices webinar. HTA events kick off again in September: you can find links to register for all the workshops and other upcoming events on the HTA website.
Links to everything discussed above and more are provided below. If you have any comments or suggestions to improve our monthly roundup, we would love to hear from you! As always, thanks for subscribing to the HTA.
HTA news
Key Insights for Collaboration Success
Will Perry, Apagie In this month’s blog Will Perry of Apagie, provider of the HTA Introduction to Knowing your Customer and your Market workshops, shares collaboration insights from an interview with Doug Leach, Vice President, Device Innovation at the Hospital for Special Surgery in New York.
Webinar Recording: European Market Access for Medical Devices
On 14 June the HTA hosted a webinar with regulatory expert Juan M. Campos discussing the European regulatory landscape for medical devices - the recording (excluding Q&A) is now available to view.
1 September 2022, online | Facilitated by Tim McCready of BioPacific Partners This online introduction workshop is tailored for the specific challenges of capital raising faced by healthtech companies. We encourage those early to mid-stage healthtech companies seeking to raise capital for the first time (outside their immediate networks) to attend.
Introduction to Knowing your Customer and your Market Workshop
15 September 2022, Christchurch | Facilitated by Dan Hansen & Will Perry of Apagie This popular in-person workshop is part of the HTA market validation series and is aimed at early-stage healthtech companies, or healthtech companies that would like to have a fresh look at their market and how they have validated it to date.
In-person in Christchurch for the first time, this workshop is run by Dan Hansen and Will Perry from Apagie, who use their cross-industry experience to give companies the right processes and perspectives for successfully commercialising their health technology.
You can view more upcoming HTA events and e-learning on the HTA website.
Other community events
Cleaning up on the world stage: Achieving scale with intangible assets
11 August, Auckland and Online A challenge for many founders and management teams is how to scale and grow quickly, while at the same time protecting and growing value in the intangible assets that underpin their company’s competitive edge.
Hosted by Callaghan Innovation and Auckland Unlimited, join this event in-person or online to hear from a panel of clean and deep technology founders and experts about the lessons they’ve learned on their journeys and what they wished they would have known when starting out.
Kimer Med were awarded a project grant of up to $150,000 in co-funding from Callaghan Innovation for the development of a broad-spectrum antiviral (7 July: RNZ)
Alimetry is the sole NZ company out of 20 startups selected for the 2022 APAC Accelerator, with a final winner getting a non-dilutive cash prize (19 July: Business Wire)
